Nafarelin 76932-56-4
| Systematic (IUPAC) name: |
(2R)-N-[(2R)-5-carbamimidamido-1-[(2S)-2-[(carbamoylmethyl)carbamoyl]pyrrolidin-1-yl]-1-oxopentan-2-yl]-2-[(2R)-2-[(2R)-2-[(2R)-3-hydroxy-2-[(2S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2R)-5-oxopyrrolidin-2-yl]formamido}propanamido]-3-(1H-indol-3-yl)propanamido]propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(naphthalen-2-yl)propanamido]-4-methylpentanamide |
| Nafarelin CAS number: |
76932-56-4 |
| ATC code: |
H01CA02 |
| PubChem: |
APRD01129 |
| DrugBank: |
APRD01129 |
| Formula: |
C66H83N17O13 |
| Molecular mass: |
1321.6344 g/mol |
| Nafarelin Assay/Purity: |
Typically NLT 98% |
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
